← Leaderboards
Benjamin Douglas Korman
Northwestern University At Chicago
$2,969,293
Attributed
$2,969,293
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $515.2K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,969,293 · 4
By mechanism
R01$1,960,562 · 1
K08$786,991 · 1
R03$151,690 · 1
F32$70,050 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Monique Evangeline Hinchcliff$3,488,191
- Peng Zhang$1,438,381
- Roberta Goncalves Marangoni$231,750
- Swati Bhattacharyya$714,817
- Seok Jong Hong$387,200
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsMorbidity - Disease RateAffectPhenotypeFibrosisGenomicsSignal TransductionPathogenesisMouse ModelMortalityTranscriptome SequencingCellsInsightFibroblastsIn VivoBiologyFutureNational Institute Of Arthritis And Musculoskeletal And Skin DiseasesEffective TherapyCytokineAnimal ModelLeadHomeostasisProteins
Grant awards (14)
Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment$454,991
R01 · FY2025 · AR · contact PI
Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment$496,637
R01 · FY2024 · AR · contact PI
Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment$515,173
R01 · FY2023 · AR · contact PI
Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment$493,761
R01 · FY2022 · AR · contact PI
Role of the Alternative Complement Cascade in Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH)$74,690
R03 · FY2021 · AR · contact PI
Contribution of Adipocytes and Adipose Secreted Factors to Fibrosis in Systemic Sclerosis$157,245
K08 · FY2020 · AR · contact PI
Role of the Alternative Complement Cascade in Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH)$77,000
R03 · FY2020 · AR · contact PI
Contribution of Adipocytes and Adipose Secreted Factors to Fibrosis in Systemic Sclerosis$157,245
K08 · FY2019 · AR · contact PI
Contribution of Adipocytes and Adipose Secreted Factors to Fibrosis in Systemic Sclerosis$766
K08 · FY2019 · AR · contact PI
Contribution of Adipocytes and Adipose Secreted Factors to Fibrosis in Systemic Sclerosis$157,245
K08 · FY2018 · AR · contact PI
Contribution of Adipocytes and Adipose Secreted Factors to Fibrosis in Systemic Sclerosis$157,245
K08 · FY2017 · AR · contact PI
Contribution of Adipocytes and Adipose Secreted Factors to Fibrosis in Systemic Sclerosis$157,245
K08 · FY2016 · AR · contact PI
PPAR-Gamma's Role in Aberrant Adipogenesis and Fibrosis in Systemic Sclerosis$8,183
F32 · FY2014 · AR · contact PI
PPAR-Gamma's Role in Aberrant Adipogenesis and Fibrosis in Systemic Sclerosis$61,867
F32 · FY2013 · AR · contact PI